Breast Neoplasms Clinical Trials in Westbrook, Maine

4 studies are recruiting for breast neoplasms in Westbrook, Maine right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

    This is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatment group. This trial will be double-blinded, which means neither the participants nor the trial doctors will know which of the two treatment…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    New England Cancer Specialists, Westbrook, Maine
    Locations
    202 in total
    Run by
    BioNTech SE

    See if you can join NCT07173751 on ClinicalTrials.gov

  2. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting worse or coming back after treatment * Early-stage, which means the cancer is in the breast or the lymph nodes around the breast The 2 types of…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    New England Cancer Specialists ( Site 0051), Westbrook, Maine
    Locations
    325 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06966700 on ClinicalTrials.gov

  3. A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

    The purpose of the study is to assess the efficacy and safety of the addition of Tersolisib (LY4064809/STX-478) to other anti-cancer drugs as first treatment for advanced hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Participants can remain…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    New England Cancer Specialists, Westbrook, Maine
    Locations
    360 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07174336 on ClinicalTrials.gov

  4. Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

    The purpose of this study is to evaluate the efficacy and safety of ctDNA-guided initiation of CDK4/6 inhibitor therapy using the Signatera™ Designed on Genome test (referred to as "Signatera Genome") in participants with intermediate-risk HR+/HER2- early-stage breast cancer. Based on ctDNA test re…

    Stage
    Not phased
    Ages
    18 and older
    Site
    New England Cancer Specialists, Westbrook, Maine
    Locations
    49 in total
    Run by
    Natera, Inc.

    See if you can join NCT07214532 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.